Trial Outcomes & Findings for Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles (NCT NCT03878758)
NCT ID: NCT03878758
Last Updated: 2020-03-09
Results Overview
Injection pain as measured by a relative visual analog scale. This endpoint analyzes data for individual groups. User preference is assessed through a single question reported on a 150mm relative VAS scale with the BD Nano™ PRO pen needle Pen labeled at +75 mm and the Comparator pen needle labeled at -75mm. On this scale, zero represents no preference to either pen needle. Relative VAS scores range from -75mm to 75mm; positive scores reflect preference forBD Nano™ PRO and negative scores reflect preference for the comparator. Scores from each of the paired injections (308 pairs for all participants) were pooled and a mean was calculated. The two-sided 95% confidence interval was calcuated for the average relative rating. A linear model was used to adjust for the order effect. If the lower bound of the 95% CI is \> -10cm, non-inferiority could be concluded. If the lower bound of the 95% CI is \>0, superiority can also be concluded.
COMPLETED
NA
158 participants
Scores were collected immediately after each paired injection
2020-03-09
Participant Flow
Each subject received more than one treatment
Participant milestones
| Measure |
All Study Participants
Subjects are to perform 6 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G or Artsana Insupen Extr3me 3.5mm x 34G or Simple Diagnostics Comfort EZ™ 4mm x 33G
|
|---|---|
|
Overall Study
STARTED
|
158
|
|
Overall Study
COMPLETED
|
154
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
| Measure |
All Study Participants
Subjects are to perform 6 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G or Artsana Insupen Extr3me 3.5mm x 34G or Simple Diagnostics Comfort EZ™ 4mm x 33G
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
|
Overall Study
Protocol defined
|
2
|
|
Overall Study
Improper consent documentation
|
1
|
Baseline Characteristics
Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles
Baseline characteristics by cohort
| Measure |
All Study Participants
n=157 Participants
Subjects are to perform 6 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G or Artsana Insupen Extr3me 3.5mm x 34G or Simple Diagnostics Comfort EZ™ 4mm x 33G
|
|---|---|
|
Age, Continuous
|
56.2 years
STANDARD_DEVIATION 11.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
77 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
80 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
12 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
145 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
23 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
12 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
16 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
88 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
16 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Scores were collected immediately after each paired injectionPopulation: Per-protocol population
Injection pain as measured by a relative visual analog scale. This endpoint analyzes data for individual groups. User preference is assessed through a single question reported on a 150mm relative VAS scale with the BD Nano™ PRO pen needle Pen labeled at +75 mm and the Comparator pen needle labeled at -75mm. On this scale, zero represents no preference to either pen needle. Relative VAS scores range from -75mm to 75mm; positive scores reflect preference forBD Nano™ PRO and negative scores reflect preference for the comparator. Scores from each of the paired injections (308 pairs for all participants) were pooled and a mean was calculated. The two-sided 95% confidence interval was calcuated for the average relative rating. A linear model was used to adjust for the order effect. If the lower bound of the 95% CI is \> -10cm, non-inferiority could be concluded. If the lower bound of the 95% CI is \>0, superiority can also be concluded.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Injection Site Pain for BD Nano PRO Needle Compared to Each of Three (3) Commercially Available Comparators
|
17.55 mm
Interval 11.43 to 23.67
|
17.39 mm
Interval 11.28 to 23.51
|
9.13 mm
Interval 3.01 to 15.25
|
SECONDARY outcome
Timeframe: Scores were collected immediately after each paired injectionPopulation: Per protocol population
Participants reported a visual score of needle bending. A score of at least 2, corresponding to \>10 degrees of bending, was considered an event of a bent needle. Scores from each injection (308 for each needle type) were pooled and a mean was calculated. The incidence of bent needle events in the BD Nano™ PRO and each competitor were compared and the mean difference reported with a 95% confidence interval.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Needle Bending in BD Nano™ PRO vs Each of 3 Comparator Pen Needles
|
-0.39 Difference in incidence
Interval -1.82 to 1.04
|
0.13 Difference in incidence
Interval -2.8 to 3.06
|
0.42 Difference in incidence
Interval -1.91 to 2.75
|
SECONDARY outcome
Timeframe: Leakage was measured directly after each injectionPopulation: Per protocol population
After saline delivery equivalent to 30U of U100 insulin (0.3mL) and subject removal of pen needle from body, study staff used the provided materials and scale to absorb leakage from the pen needle tip and injection site to measure the amount of leakage. Leakage over 0.015g was counted as an event. The incidence of leakage (yes/no) was calculated for each groups and the mean difference calculated along with a 95% confidence interval. A positive score indicates fewer leakage events with the BD Nano™ PRO and a negative score indicates fewer leakage events with the competitor. Scores from each injection (308 for each needle type) were pooled and a mean was calculated. The incidence of needle leakage in the BD Nano™ PRO and each comparator were compared and the mean difference reported with a 95% confidence interval.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=308 Pen Needles
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
n=308 Pen Needles
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
n=308 Pen Needles
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Superiority of BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Leakage)
|
-5.70 Difference in incidence
Interval -9.0 to -3.5
|
-14.09 Difference in incidence
Interval -26.49 to -1.69
|
-0.20 Difference in incidence
Interval -1.9 to 0.6
|
SECONDARY outcome
Timeframe: Immediately after injection PairPopulation: Subjects protocol population with non-missing data
Subject perceived force required to deliver dose; measured by a relative 5 point Likert scale. The scale ranged from -2 to 2, where positive scores indicated less thumb force required for the BD Nano™ PRO, and negative scores indicated less thumb force for the comparator. Scores from each of the paired injections were pooled and a mean was calculated.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=306 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
n=305 paired injections
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
n=307 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Force)
|
0.8 Score on a scale
Interval 0.62 to 0.98
|
1.0 Score on a scale
Interval 0.8 to 1.16
|
0.3 Score on a scale
Interval 0.13 to 0.49
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Time of injectionPopulation: Per Protocol Population
Time from when subject when is depressed and time when removed from body.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=1848 Pen needles
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Total Injection Time)
BD NANO
|
8.39 seconds
Standard Deviation 5.26
|
—
|
—
|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Total Injection Time)
Artsana 33G
|
10.98 seconds
Standard Deviation 2.64
|
—
|
—
|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Total Injection Time)
Arstana 34G
|
9.93 seconds
Standard Deviation 5.16
|
—
|
—
|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Total Injection Time)
Comfort EZ 33G
|
8.63 seconds
Standard Deviation 5.30
|
—
|
—
|
POST_HOC outcome
Timeframe: Immediately after injectionPopulation: Per Protocol Population
A needle was considered broken if the patient end and canula was separated into 2 pieces. The number and proportion of needle breaking occurrence for each pen needle type were summarized. The incidence of broken needle events for the BD Nano PRO was compared to each of the 3 comparator products and the mean difference reported with a 95% confidence interval.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
n=308 paired injections
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Compare BD Nano™ PRO vs Each of 3 Comparator Pen Needles (Needle Breaking)
|
0 Difference in incidence
Interval -0.4 to 1.2
|
0 Difference in incidence
Interval -0.4 to 1.2
|
0 Difference in incidence
Interval -0.4 to 1.2
|
POST_HOC outcome
Timeframe: At the end of studyPopulation: Each subject was provided a 4 question survey of their general experience with pen needles. The questions were based on a a 5 point type of Likert scale.
Each subject was given a non-comparative 4-question survey on Pen needle characteristics.
Outcome measures
| Measure |
BD Nano™ PRO Pen Needle vs 34G Artsana Insupen Extr3me
n=154 Participants
Subjects are to perform 2 pairs of injections. Each pair consists of Nano™ PRO pen needle vs Artsana Insupen Extr3me 3.5mm x 34G x 2
BD Nano™ PRO: Insulin Pen needle
34G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs 33G Artsana Insupen Extr3me
Subjects are to perform 2 pairs of injections. Each Pair consists of BD Nano™ PRO pen needle vs Artsana Insupen Extr3me 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
33G Artsana Insupen Extr3me: Insulin Pen Needle
|
BD Nano™ PRO Pen Needle vs Simple Diagnostics Comfort EZ™
Subjects are to perform 2 pairs of injections. Each pair consists of BD Nano™ PRO pen needle vs Simple Diagnostics Comfort EZ™ 4mm x 33G x 2
BD Nano™ PRO: Insulin Pen needle
Simple Diagnostics Comfort EZ™: Insulin Pen Needle
|
|---|---|---|---|
|
Subject Satisfaction Survey
Post injection leakage affects my level of concern · Somewhat Agree
|
31 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Post injection leakage affects my level of concern · Neutral
|
23 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Injection pain affects my level of satisfaction · Agree
|
56 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Injection pain affects my level of satisfaction · Somewhat Agree
|
46 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Injection pain affects my level of satisfaction · Neutral
|
27 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Injection pain affects my level of satisfaction · Somewhat disagree
|
8 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Injection pain affects my level of satisfaction · Disagree
|
17 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Thumb pressure affects my level of satisfaction · Agree
|
54 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Thumb pressure affects my level of satisfaction · Somewhat Agree
|
51 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Thumb pressure affects my level of satisfaction · Neutral
|
26 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Thumb pressure affects my level of satisfaction · Somewhat disagree
|
9 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Thumb pressure affects my level of satisfaction · Disagree
|
14 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Post injection leakage affects my level of concern · Agree
|
76 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Post injection leakage affects my level of concern · Somewhat disagree
|
8 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
Post injection leakage affects my level of concern · Disagree
|
16 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
A bend needle increases my level of concern · Agree
|
100 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
A bend needle increases my level of concern · Somewhat Agree
|
28 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
A bend needle increases my level of concern · Neutral
|
13 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
A bend needle increases my level of concern · Somewhat disagree
|
2 Participants
|
—
|
—
|
|
Subject Satisfaction Survey
A bend needle increases my level of concern · Disagree
|
11 Participants
|
—
|
—
|
Adverse Events
BD Nano™ PRO Pen Needle
34G Artsana Insupen Extr3me
33G Artsana Insupen Extr3me
Simple Diagnostics Comfort EZ™
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place